Ivermectin use in children below 15 kg: potential benefits for onchocerciasis and scabies elimination programs.
We read with interest the paper by M Levy et al about the treatment of scabies with ivermectin in infants and children under 15kg of body weight1 . The authors describe the results of a multicentre observational study conducted in France between 2012-15, among 170 children with body weight 4 to 14.5kg. Children were treated with a mean dose of ivermectin of 223µg/kg, and 89% of them had received two doses. Adverse events were observed in only seven participants (4%), none of which were severe. Therefore, they concluded that a therapeutic trial in infants and young children needs to be performed.